U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07162779) titled 'Evaluation of [68Ga]DOTA-IR-780-C-4 in PET Imaging Studies for PSMA-Positive Prostate Cancer Patients' on July 28.
Brief Summary: Prostate cancer is one of the most common malignant tumors in the urinary and male reproductive systems. According to the 2020 edition of the Global Cancer Statistics Report published by the WHO International Agency for Research on Cancer in February 2021, newly diagnosed prostate cancer cases worldwide accounted for 7.3% of all malignant tumors in 2020, with an incidence rate ranking third after breast cancer and lung cancer. Deaths from prostate cancer accounted for 3.8% of all malignant tumor deaths, ...